Literature DB >> 6292745

[125I] N6-p-Hydroxyphenylisopropyladenosine, a new ligand for Ri adenosine receptors.

U Schwabe, V Lenschow, D Ukena, D R Ferry, H Glossmann.   

Abstract

N6-p-Hydroxyphenylisopropyladenosine (HPIA) has been labelled with carrier-free Na[125I] to very high specific activity (2,175 Ci/mmol) and used as an agonist ligand to characterize Ri adenosine receptors in rat cerebral cortex membranes. The binding is saturable, reversible, stereospecific and dependent on protein concentration. The specific binding at 37 degrees C was of high affinity with an equilibrium dissociation constant KD of 0.48 nmol/l and was saturable with 0.23 pmol of [125I]HPIA per mg of protein. The rate constant of association, k1, was 3.25 x 10(8) l mol-1 min-1 and that of dissociation, k2 0.0110 min-1 yielding at t1/2 of 63 min. In competition experiments the (-)isomer of N6-phenylisopropyladenosine (PIA) was 16-fold more potent than the (+)isomer in competing for binding sites. Specific binding was most effectively displaced by N6-cyclohexyladenosine (CHA, ki=0.26 nmol/l), (-)PIA (ki= 0.33 nmol/l) and HPIA (ki=0.52 nmol/l), whereas 5'-N-ethylcarboxamidoadenosine (NECA, ki=1.42 nmol/l) was less effective. The methylxanthines 3-isobutyl-1-methylxanthine (IBMX), theophylline and caffeine which have been classified as adenosine antagonists had ki values between 5-43 mumol/l. Binding of [125I]HPIA was regulated by guanine nucleotides and divalent cations. The results indicate that [125I]HPIA labels Ri adenosine receptors in rat brain membranes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292745     DOI: 10.1007/bf00586356

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  9 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Alpha noradrenergic receptors in brain membranes: sodium, magnesium and guanyl nucleotides modulate agonist binding.

Authors:  H Glossmann; P Presek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-01       Impact factor: 3.000

Review 3.  Adenosine receptors: targets for future drugs.

Authors:  J W Daly
Journal:  J Med Chem       Date:  1982-03       Impact factor: 7.446

4.  Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine.

Authors:  U Schwabe; T Trost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

5.  Subclasses of external adenosine receptors.

Authors:  C Londos; D M Cooper; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

6.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

7.  The dextro and levorotatory isomers of N-phenylisopropyladenosine: stereospecific effects on cyclic AMP-formation and evoked synaptic responses in brain slices.

Authors:  F W Smellie; J W Daly; T V Dunwiddie; B J Hoffer
Journal:  Life Sci       Date:  1979-11-12       Impact factor: 5.037

8.  Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine.

Authors:  R F Bruns; J W Daly; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

9.  Guanine nucleotide and cation regulation of the binding of [3H]cyclohexyladenosine and [3H]diethylphenylxanthine to adenosine A1 receptors in brain membranes.

Authors:  R R Goodman; M J Cooper; M Gavish; S H Snyder
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

  9 in total
  13 in total

1.  Pharmacological characterization of A1 adenosine receptors in isolated rat ventricular myocytes.

Authors:  D Martens; M J Lohse; B Rauch; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

2.  Evidence for altered expression of the GTP-dependent regulatory proteins, Gs and Gi, in adipocytes from aged rats.

Authors:  A Green; J L Johnson
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

3.  Labelling of Ri adenosine receptors in rat fat cell membranes with (-)-[125iodo]N6-hydroxyphenylisopropyladenosine.

Authors:  D Ukena; R Furler; M J Lohse; G Engel; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

4.  Effects of several 5'-carboxamide derivatives of adenosine on adenosine receptors of human platelets and rat fat cells.

Authors:  D Ukena; E Böhme; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-08       Impact factor: 3.000

5.  Demonstration of Ri-type adenosine receptors in bovine myocardium by radioligand binding.

Authors:  M J Lohse; D Ukena; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

6.  Ra adenosine receptors in human platelets. Characterization by 5'-N-ethylcarboxamido[3H]adenosine binding in relation to adenylate cyclase activity.

Authors:  E Hüttemann; D Ukena; V Lenschow; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

7.  Glomeruli and microvessels of the rabbit kidney contain both A1- and A2-adenosine receptors.

Authors:  M Freissmuth; V Hausleithner; E Tuisl; C Nanoff; W Schütz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

8.  Chronic administration of theophylline to rats induces a post-insulin binding defect in adipocyte glucose transport.

Authors:  A Green
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

9.  Endogenous adenosine and adenosine receptors localized to ganglion cells of the retina.

Authors:  K M Braas; M A Zarbin; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

10.  Characterization of forskolin binding sites in rat brain membranes using [14,15-3H]14,15-dihydroforskolin as a ligand.

Authors:  K Schmidt; R Munshi; H P Baer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.